Jeremy S. Thomas

发表

Mammostrat® as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

Hans Christian Pedersen, D. Ross, B. Ring, 2010, Breast Cancer Research.

Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.

A. Turnbull, Jeremy S. Thomas, J. Dixon, 2017, Cancer treatment reviews.

Edinburgh Explorer Nottingham Prognostic Index Plus (NPI+): Validation of a clinical decision making tool in breast cancer in an independent series

David Cameron, Daniele Soria, Jacqueline Stephen, 2015 .

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials

Lars J. Grimm, E. Shelley Hwang, Alastair M. Thompson, 2017, Annals of Surgical Oncology.

MolecularChanges inLobularBreastCancers inResponse to Endocrine Therapy

A. Turnbull, Jeremy S. Thomas, J. Dixon, 2014 .

DCIS and aromatase inhibitors

J. Dixon, D. Faratian, Jeremy S. Thomas, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer

J. Bartlett, D. Cameron, E. Mallon, 2012, Breast Cancer Research and Treatment.

Determining tamoxifen sensitivity using primary breast cancer tissue in collagen-based three-dimensional culture.

D. Harrison, Jeremy S. Thomas, J. Dixon, 2012, Biomaterials.

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.

C. Caldas, E. Provenzano, J. Abraham, 2015, The Lancet. Oncology.

Proximity ligation assays for isoform‐specific Akt activation in breast cancer identify activated Akt1 as a driver of progression

G. Kerr, J. Bartlett, D. Cameron, 2012, The Journal of pathology.

Management of Regional Nodes in Breast Cancer

J. Dixon, Jeremy S. Thomas, N. Bundred, 2013 .

Retrieval, handling and assessment of lymph nodes in cancer resection specimens

Jeremy S. Thomas, J. Thomas, 2006 .

P097. Intra-operative assessment of excision margins in breast conserving surgery for breast cancer using ClearEdge imaging device

J. Dixon, Jeremy S. Thomas, J. Keys, 2015 .

Symptoms, Assessment and Guidelines for Referral

J. Dixon, Jeremy S. Thomas, 2012 .

Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery

Jeremy S. Thomas, L. Williams, J. Michael Dixon, 2016, Breast Cancer Research and Treatment.

Abstract OT2-3-01: The LORIS trial: A multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ

S. Pinder, M. Wallis, L. Fallowfield, 2013 .

Edinburgh Research Explorer Estrogen-induced chromatin decondensation and nuclear reorganization linked to regional epigenetic regulation in breast cancer

W. Bickmore, Jeremy S. Thomas, D. Sproul, 2017 .

Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole.

M. Ellis, M. Dowsett, Y. Tao, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

uorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

E. Provenzano, J. Abraham, J. Bartlett, 2015 .

Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology

D. Treanor, P. Tan, Jeremy S. Thomas, 2018, Journal of Clinical Pathology.

The diagnosis of lymphoid infiltrates in the bone marrow trephine

Jeremy S. Thomas, J. Thomas, 2004 .

In regard to Moran et al.

J. Dixon, Jeremy S. Thomas, 2014, International journal of radiation oncology, biology, physics.

Authors' Reply

G. Kerr, J. Bartlett, D. Cameron, 2013, The Journal of pathology.

GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients

G. Kerr, J. Bartlett, U. Chetty, 2012, Breast Cancer Research and Treatment.

A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH

I. Ellis, J. Bartlett, F. Campbell, 2010, Histopathology.